Alkermes
ALKS · NASDAQ
Bulios Fair Price
$40.35
7.0% downside
Current Price
$43.39
According to Bulios Fair Price, ALKS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Alkermes plc is a global biotechnology company focused on the development and manufacturing of innovative medicines for the treatment of neuropsychiatric and oncological diseases. Founded in 1987 and headquartered in Dublin, Ireland, Alkermes specializes in developing drugs for the treatment of mental health disorders such as schizophrenia, depression, and addiction, as well as cancer therapies. The company is known for its technology in the production of long-acting injectable medications, aiming to provide patients with effective and accessible treatment options.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Blair Jackson
Employees
2,050
Headquarters
Dublin
Upcoming events
Earnings
Upcoming earnings report